Dosimetric predictors of hypothyroidism in oropharyngeal cancer patients treated with intensity-modulated radiation therapy

Radiation Oncology

Sue S Yom¹  Jeanne M Quivey¹  Louise Lambert¹  Erin Shugard¹  Josephine Chen¹  Arthur Chyan¹ 

[1] Department of Radiation Oncology, University of California, San Francisco, 1600 Divisadero Street, Suite H1031, San Francisco 94115, CA, USA

关键词: Normal tissue toxicity;    Intensity-modulated radiation therapy;    Hypothyroidism;    Oropharyngeal cancer;   

Others  :  1150739
DOI  :  10.1186/s13014-014-0269-4

 received in 2014-08-11, accepted in 2014-11-20,  发布年份 2014

【 摘 要 】

Background

Radiation to the neck has long been associated with an elevated risk of hypothyroidism development. The goal of the present work is to define dosimetric predictors of hypothyroidism in oropharyngeal cancer (OPC) patients treated with intensity-modulated radiation therapy.

Methods

Data for 123 patients, with a median follow up of 4.6 years, were retrospectively analyzed. Patients with elevated thyroid-stimulating hormone levels or with a clinical diagnosis were categorized as hypothyroid. Patient demographic parameters, thyroid volume, mean thyroid dose, the percent of thyroid volume receiving minimum specified dose levels (VxxGy), and the absolute thyroid volume spared from specified dose levels (VSxxGy) were analyzed. Normal-tissue complication probability (NTCP) was also calculated using several recently published models.

Results

Thyroid volume and many radiation dosimetric parameters were statistically different in the hypothyroid group. For the patients with initial thyroid volumes of 8 cc or greater, several dosimetric parameters were found to define subgroups at statistically significant lower risk of developing hypothyroidism. Patients with VS45 Gy of at least 3 cc, VS50 Gy at least 5 cc, VS50 Gy at least 6 cc, V50 Gy below 45%, V50 Gy below 55%, or mean thyroid dose below 49 Gy had a 28-38% estimated risk of hypothyroidism at 3 years compared to a 55% risk for the entire study group. Patients with a NTCP of less than 0.75 or 0.8, calculated using recently published models, were also observed to have a lower risk of developing hypothyroidism.

Conclusions

Based on long-term follow up data for OPC patients treated with IMRT, we recommend plan optimization objectives to reduce the volume of thyroid receiving over 45 Gy to significantly decrease the risk of developing hypothyroidism.

【 授权许可】

   
2014 Chyan et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Hancock SL, Cox RS, McDougall IR: Thyroid diseases after treatment of Hodgkin’s disease. N Engl J Med 1991, 325:599-605.
• [2]Weissler MC, Berry BW: Thyroid-stimulating hormone levels after radiotherapy and combined therapy for head and neck cancer. Head Neck 1991, 13:420-423.
• [3]Grande C: Hypothyroidism following radiotherapy for head and neck cancer: multivariate analysis of risk factors. Radiother Oncol 1992, 25:31-36.
• [4]Kuten A, Lubochitski R, Fishman G, Dale J, Stein ME: Postradiotherapy hypothyroidism: radiation dose response and chemotherapeutic radiosensitization at less than 40 Gy. J Surg Oncol 1996, 61:281-283.
• [5]Tell R, Sjodin H, Lundell G, Lewin F, Lewensohn R: Hypothyroidism after external radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 1997, 39:303-308.
• [6]Vogelius IR, Bentzen SM, Maraldo MV, Petersen PM, Specht L: Risk factors for radiation-induced hypothyroidism: a literature-based meta-analysis. Cancer 2011, 117:5250-5260.
• [7]Bhandare N, Kennedy L, Malyapa RS, Morris CG, Mendenhall WM: Primary and central hypothyroidism after radiotherapy for head-and-neck tumors. Int J Radiat Oncol Biol Phys 2007, 68:1131-1139.
• [8]Alterio D, Jereczek-Fossa BA, Franchi B, D'Onofrio A, Piazzi V, Rondi E, Ciocca M, Gibelli B, Grosso E, Tradati N, Mariani L, Boboc GI, Orecchia R: Thyroid disorders in patients treated with radiotherapy for head-and-neck cancer: a retrospective analysis of seventy-three patients. Int J Radiat Oncol Biol Phys 2007, 67:144-150.
• [9]Diaz R, Jaboin JJ, Morales-Paliza M, Koehler E, Phillips JG, Stinson S, Gilbert J, Chung CH, Murphy BA, Yarbrough WG, Murphy PB, Shyr Y, Cmelak AJ: Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2010, 77:468-476.
• [10]Lin Z, Wu VW, Lin J, Feng H, Chen L: A longitudinal study on the radiation-induced thyroid gland changes after external beam radiotherapy of nasopharyngeal carcinoma. Thyroid 2011, 21:19-23.
• [11]Johansen S, Reinertsen KV, Knutstad K, Olsen DR, Fossa SD: Dose distribution in the thyroid gland following radiation therapy of breast cancer – a retrospective study.Radiat Oncol 2011, 6:68.
• [12]Cella L, Conson M, Caterino M, De Rosa N, Liuzzi R, Picardi M, Grimaldi F, Solla R, Farella A, Salvatore M, Pacelli R: Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin’s lymphoma. Int J Radiat Oncol Biol Phys 2012, 82:1802-1808.
• [13]Cella L, Liuzzi R, Conson M, D'Avino V, Salvatore M, Pacelli R: Development of multivariate NTCP models for radiation-induced hypothyroidism: a comparative analysis.Radiat Oncol 2012, 7:224.
• [14]Boomsma MJ, Bijl HP, Christianen ME, Beetz I, Chouvalova O, Steenbakkers RJ, van der Laan BF, Wolffenbuttel BH, Oosting SF, Schilstra C, Langendijk JA: A prospective cohort study on radiation-induced hypothyroidism: development of an NTCP model. Int J Radiat Oncol Biol Phys 2012, 84:e351-e356.
• [15]Bakhshandeh M, Hashemi B, Mahdavi SR, Nikoofar A, Vasheghani M, Kazemnejad A: Normal tissue complication probability modeling of radiation-induced hypothyroidism after head-and-neck radiation therapy. Int J Radiat Oncol Biol Phys 2013, 85:514-521.
• [16]Ronjom MF, Brink C, Bentzen SM, Hegedus L, Overgaard J, Johansen J: Hypothyroidism after primary radiotherapy for head and neck squamous cell carcinoma: Normal tissue complication probability modeling with latent time correction. Radiother Oncol 2013, 109:317-322.
• [17]Fein DA, Hanlon AL, Corn BW, Curran WJ, Coia LR: The influence of lymphangiography on the development of hypothyroidism in patients irradiated for Hodgkin’s disease. Int J Radiat Oncol Biol Phys 1996, 36:13-18.